| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.18B | 9.24B | 7.40B | 6.07B | 4.63B | 3.50B |
| Gross Profit | 4.30B | 3.84B | 3.26B | 2.62B | 1.85B | 1.27B |
| EBITDA | 1.45B | 1.16B | 1.32B | 816.81M | 302.09M | -240.67M |
| Net Income | 1.00B | 849.37M | 1.37B | 690.67M | 294.11M | -273.59M |
Balance Sheet | ||||||
| Total Assets | 8.67B | 7.34B | 4.41B | 3.04B | 1.94B | 1.86B |
| Cash, Cash Equivalents and Short-Term Investments | 3.75B | 4.30B | 2.52B | 1.58B | 928.69M | 1.03B |
| Total Debt | 1.89B | 2.08B | 69.61M | 17.21M | 0.00 | 9.60M |
| Total Liabilities | 4.03B | 3.47B | 1.43B | 1.51B | 1.16B | 1.52B |
| Stockholders Equity | 4.55B | 3.82B | 2.89B | 1.50B | 720.42M | 302.36M |
Cash Flow | ||||||
| Free Cash Flow | 1.02B | 672.92M | 976.37M | 811.41M | -75.45M | 400.49M |
| Operating Cash Flow | 1.35B | 930.18M | 1.07B | 851.34M | 21.97M | 419.62M |
| Investing Cash Flow | -2.15B | -1.10B | -119.95M | -200.85M | -111.71M | -29.41M |
| Financing Cash Flow | 1.82B | 1.96B | -18.32M | -1.16M | -9.60M | -18.08M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥18.96B | 13.52 | ― | 3.53% | 5.03% | -9.55% | |
80 Outperform | ¥42.34B | 8.81 | ― | 1.28% | -7.46% | 11.57% | |
75 Outperform | ¥9.54B | 12.83 | ― | 3.85% | 1.75% | 24.87% | |
73 Outperform | ¥12.03B | 9.43 | ― | 2.10% | 13.64% | 44.55% | |
66 Neutral | ¥21.69B | 23.11 | ― | ― | 30.15% | 31.28% | |
62 Neutral | ¥3.30B | 9.34 | ― | ― | -3.76% | -67.98% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |